Digitally assisted sleep medicine - developing optimised patient pathways for obstructive sleep apnoea

Digitally assisted sleep medicine - developing optimised patient pathways for obstructive sleep apnoea - SLEEP WELL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027895

Enrollment

4448

Registered

2022-04-01

Start date

2022-04-01

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.31

Interventions

Group 1: Control group: established step-by-step diagnostics and therapy initiation according to clinical routine Group 2: Telemedicine group: established step-by-step diagnosis and therapy initiation

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patient with suspected obstructive sleep apnoea according to standardised questionnaire

Exclusion criteria

Exclusion criteria: Acute or untreated internal, neurological or psychiatric disease, known obstructive sleep apnoea (OSA) with condition after PAP therapy intolerance.

Design outcomes

Primary

Measure	Time frame
Disease-related quality of life Surveyed at the times: - initiation - after 3 months - after 6 months - after 12 months How: FOSQ-10 questionnaire	—

Secondary

Measure	Time frame
Adherence of therapy, termination rate of therapy, satisfaction/acceptance with the additional telemedical support.	—

Countries

Germany

Contacts

Public ContactChristoph Schöbel

Universitätsmedizin Essen, Ruhrlandklinik - Westdeutsches Lungenzentrum, Zentrum für Schlaf- und Telemedizin

sleep-well@uk-essen.de0201-433-01

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026